FIBROGEN INC - COMMON

FibroGen to Participate at Bank of America 2022 Biotech SMID Cap Virtual Conference

28 ноя 2022 04:00:00 Источник Nasdaq GlobeNewswire

FibroGen Reports Third Quarter 2022 Financial Results

07 ноя 2022 13:01:00 Источник Nasdaq GlobeNewswire

FibroGen Announces $50 Million Royalty Monetization Financing with NovaQuest Capital Management

07 ноя 2022 13:00:00 Источник Nasdaq GlobeNewswire

FibroGen to Participate at Stifel 2022 Healthcare Conference

01 ноя 2022 04:00:01 Источник Nasdaq GlobeNewswire

FibroGen to Report Third Quarter 2022 Financial Results

24 окт 2022 04:00:00 Источник Nasdaq GlobeNewswire

FibroGen Announces Completion of Patient Enrollment in MATTERHORN, a Phase 3 Clinical Study of Roxadustat for the Treatment of Anemia in Patients with Lower Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS)

26 авг 2022 04:00:00 Источник Nasdaq GlobeNewswire

FibroGen Reports Second Quarter 2022 Financial Results

08 авг 2022 13:01:00 Источник Nasdaq GlobeNewswire

FibroGen to Report Second Quarter 2022 Financial Results

25 июл 2022 04:00:33 Источник Nasdaq GlobeNewswire

FibroGen to Participate at William Blair Biotech Focus Conference 2022

01 июл 2022 04:00:00 Источник Nasdaq GlobeNewswire

FibroGen Announces Completion of Patient Enrollment in LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Duchenne Muscular Dystrophy

08 июн 2022 04:00:01 Источник Nasdaq GlobeNewswire

FibroGen to Present at Jefferies Healthcare Conference

26 май 2022 04:00:00 Источник Nasdaq GlobeNewswire

FibroGen Reports First Quarter 2022 Financial Results

09 май 2022 13:01:00 Источник Nasdaq GlobeNewswire

FibroGen to Report First Quarter 2022 Financial Results

25 апр 2022 04:00:00 Источник Nasdaq GlobeNewswire

FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis

20 апр 2022 04:00:01 Источник Nasdaq GlobeNewswire

FibroGen Reports Fourth Quarter and Full Year 2021 Financial Results

28 фев 2022 13:01:00 Источник Nasdaq GlobeNewswire

FibroGen to Report Fourth Quarter and Full Year 2021 Financial Results

14 фев 2022 04:00:00 Источник Nasdaq GlobeNewswire

FibroGen to Present at SVB Leerink 11th Annual Global Healthcare Conference

04 фев 2022 04:00:00 Источник Nasdaq GlobeNewswire

FibroGen to Present at H.C. Wainwright Bioconnect Virtual Conference

04 янв 2022 04:00:02 Источник Nasdaq GlobeNewswire

FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 Program

20 дек 2021 05:00:01 Источник Nasdaq GlobeNewswire

FibroGen Reports Third Quarter 2021 Financial Results

09 ноя 2021 13:01:01 Источник Nasdaq GlobeNewswire